MUCINEX

Serial Number 76297961
Registration 2670161
800

Registration Progress

Application Filed
Aug 8, 2001
Under Examination
Apr 9, 2002
Approved for Publication
Dec 26, 2001
Published for Opposition
Jan 15, 2002
Registered
Dec 31, 2002

Basic Information

Serial Number
76297961
Registration Number
2670161
Filing Date
August 8, 2001
Registration Date
December 31, 2002
Published for Opposition
January 15, 2002
Renewal Date
December 31, 2022
Drawing Code
1000

Status Summary

Current Status
Active
Status Code
800
Status Date
Feb 28, 2023
Registration
Registered
Classes
005

Rights Holder

RB HEALTH (US) LLC

16
Address
399 INTERPACE PARKWAY
PARSIPPANY, NJ 07054

Ownership History

Adams Laboratories, Inc.

Original Applicant
03
Fort Worth, TX

Adams Laboratories, Inc.

Owner at Publication
03
Fort Worth, TX

Adams Laboratories, Inc.

Original Registrant
03
Fort Worth, TX

ADAMS RESPIRATORY THERAPEUTICS, INC.

New Owner After Registration #1
03
CHESTER, NJ

RECKITT BENCKISER INC.

New Owner After Registration #2
03
PARSIPPANY, NJ

RECKITT BENCKISER LLC

New Owner After Registration #3
16
PARSIPPANY, NJ

RB HEALTH (US) LLC

New Owner After Registration #4
16
PARSIPPANY, NJ

Legal Representation

Attorney
Mark Lerner, Esq.

USPTO Deadlines

Next Deadline
2732 days remaining
Section 8 & 9 (30-Year) Renewal Due (Based on registration date 2002-12-31)
Due Date
December 31, 2032
Grace Period Ends
June 30, 2033

Application History

35 events
Date Code Type Description
Feb 28, 2023 89AG O REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
Feb 28, 2023 RNL2 Q REGISTERED AND RENEWED (SECOND RENEWAL - 10 YRS)
Feb 28, 2023 NA89 E NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
Feb 23, 2023 APRE A CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Aug 5, 2022 E89R I TEAS SECTION 8 & 9 RECEIVED
Dec 31, 2021 REM2 E COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
Nov 21, 2018 ASGN I AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Feb 19, 2015 REAP I TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Feb 19, 2015 ARAA I ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Feb 28, 2012 89AG O REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
Feb 28, 2012 RNL1 Q REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
Feb 28, 2012 NA89 E NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
Feb 21, 2012 E89R I TEAS SECTION 8 & 9 RECEIVED
Mar 2, 2011 ASGN I AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Dec 21, 2008 C15A O REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Dec 19, 2008 PLGL A ASSIGNED TO PARALEGAL
Dec 17, 2008 E815 I TEAS SECTION 8 & 15 RECEIVED
Jul 16, 2008 ASGN I AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
May 7, 2008 CFIT O CASE FILE IN TICRS
Nov 8, 2006 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED
Jul 6, 2006 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED
Apr 12, 2006 ASCK I ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Dec 14, 2004 MAIL I PAPER RECEIVED
Dec 7, 2004 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED
Dec 31, 2002 R.PR A REGISTERED-PRINCIPAL REGISTER
Oct 21, 2002 DOCK D ASSIGNED TO EXAMINER
Oct 21, 2002 CNPR P ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Oct 16, 2002 SUPC I STATEMENT OF USE PROCESSING COMPLETE
Aug 22, 2002 MAIL I PAPER RECEIVED
Aug 22, 2002 IUAF S USE AMENDMENT FILED
Apr 9, 2002 NOAM O NOA MAILED - SOU REQUIRED FROM APPLICANT
Jan 15, 2002 PUBO A PUBLISHED FOR OPPOSITION
Dec 26, 2001 NPUB O NOTICE OF PUBLICATION
Sep 25, 2001 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER
Sep 18, 2001 DOCK D ASSIGNED TO EXAMINER

Detailed Classifications

Class 005
pharmaceutical preparations for use as an expectorant
First Use Anywhere: Jul 23, 2002
First Use in Commerce: Jul 23, 2002

Classification

International Classes
005